Cargando…

Balance Impairments as Differential Markers of Dementia Disease Subtype

BACKGROUND: Accurately differentiating dementia subtypes, such as Alzheimer’s disease (AD) and Lewy body disease [including dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD)] is important to ensure appropriate management and treatment of the disease. Similarities in clinical pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mc Ardle, Ríona, Pratt, Stephanie, Buckley, Christopher, Del Din, Silvia, Galna, Brook, Thomas, Alan, Rochester, Lynn, Alcock, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991998/
https://www.ncbi.nlm.nih.gov/pubmed/33777910
http://dx.doi.org/10.3389/fbioe.2021.639337
_version_ 1783669289365012480
author Mc Ardle, Ríona
Pratt, Stephanie
Buckley, Christopher
Del Din, Silvia
Galna, Brook
Thomas, Alan
Rochester, Lynn
Alcock, Lisa
author_facet Mc Ardle, Ríona
Pratt, Stephanie
Buckley, Christopher
Del Din, Silvia
Galna, Brook
Thomas, Alan
Rochester, Lynn
Alcock, Lisa
author_sort Mc Ardle, Ríona
collection PubMed
description BACKGROUND: Accurately differentiating dementia subtypes, such as Alzheimer’s disease (AD) and Lewy body disease [including dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD)] is important to ensure appropriate management and treatment of the disease. Similarities in clinical presentation create difficulties for differential diagnosis. Simple supportive markers, such as balance assessments, may be useful to the diagnostic toolkit. This study aimed to identify differences in balance impairments between different dementia disease subtypes and normal aging using a single triaxial accelerometer. METHODS: Ninety-seven participants were recruited, forming four groups: cognitive impairment due to Alzheimer’s disease (AD group; n = 31), dementia with Lewy bodies (DLB group; n = 26), Parkinson’s disease dementia (PDD group; n = 13), and normal aging controls (n = 27). Participants were asked to stand still for 2 minutes in a standardized position with their eyes open while wearing a single triaxial accelerometer on their lower back. Seven balance characteristics were derived, including jerk (combined, mediolateral, and anterior–posterior), root mean square (RMS; combined, mediolateral, and anterior–posterior), and ellipsis. Mann–Whitney U tests identified the balance differences between groups. Receiver operating characteristics and area under the curve (AUC) determined the overall accuracy of the selected balance characteristics. RESULTS: The PDD group demonstrated higher RMS [combined (p = 0.001), mediolateral (p = 0.005), and anterior–posterior (p = 0.001)] and ellipsis scores (p < 0.002) than the AD group (AUC = 0.71–0.82). The PDD group also demonstrated significantly impaired balance across all characteristics (p ≤ 0.001) compared to the controls (AUC = 0.79–0.83). Balance differences were not significant between PDD and DLB (AUC = 0.69–0.74), DLB and AD (AUC = 0.50–0.65), DLB and controls (AUC = 0.62–0.68), or AD and controls (AUC = 0.55–0.67) following Bonferroni correction. DISCUSSION: Although feasible and quick to conduct, key findings suggest that an accelerometer-based balance during quiet standing does not differentiate dementia disease subtypes accurately. Assessments that challenge balance more, such as gait or standing with eyes closed, may prove more effective to support differential diagnosis.
format Online
Article
Text
id pubmed-7991998
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79919982021-03-26 Balance Impairments as Differential Markers of Dementia Disease Subtype Mc Ardle, Ríona Pratt, Stephanie Buckley, Christopher Del Din, Silvia Galna, Brook Thomas, Alan Rochester, Lynn Alcock, Lisa Front Bioeng Biotechnol Bioengineering and Biotechnology BACKGROUND: Accurately differentiating dementia subtypes, such as Alzheimer’s disease (AD) and Lewy body disease [including dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD)] is important to ensure appropriate management and treatment of the disease. Similarities in clinical presentation create difficulties for differential diagnosis. Simple supportive markers, such as balance assessments, may be useful to the diagnostic toolkit. This study aimed to identify differences in balance impairments between different dementia disease subtypes and normal aging using a single triaxial accelerometer. METHODS: Ninety-seven participants were recruited, forming four groups: cognitive impairment due to Alzheimer’s disease (AD group; n = 31), dementia with Lewy bodies (DLB group; n = 26), Parkinson’s disease dementia (PDD group; n = 13), and normal aging controls (n = 27). Participants were asked to stand still for 2 minutes in a standardized position with their eyes open while wearing a single triaxial accelerometer on their lower back. Seven balance characteristics were derived, including jerk (combined, mediolateral, and anterior–posterior), root mean square (RMS; combined, mediolateral, and anterior–posterior), and ellipsis. Mann–Whitney U tests identified the balance differences between groups. Receiver operating characteristics and area under the curve (AUC) determined the overall accuracy of the selected balance characteristics. RESULTS: The PDD group demonstrated higher RMS [combined (p = 0.001), mediolateral (p = 0.005), and anterior–posterior (p = 0.001)] and ellipsis scores (p < 0.002) than the AD group (AUC = 0.71–0.82). The PDD group also demonstrated significantly impaired balance across all characteristics (p ≤ 0.001) compared to the controls (AUC = 0.79–0.83). Balance differences were not significant between PDD and DLB (AUC = 0.69–0.74), DLB and AD (AUC = 0.50–0.65), DLB and controls (AUC = 0.62–0.68), or AD and controls (AUC = 0.55–0.67) following Bonferroni correction. DISCUSSION: Although feasible and quick to conduct, key findings suggest that an accelerometer-based balance during quiet standing does not differentiate dementia disease subtypes accurately. Assessments that challenge balance more, such as gait or standing with eyes closed, may prove more effective to support differential diagnosis. Frontiers Media S.A. 2021-03-11 /pmc/articles/PMC7991998/ /pubmed/33777910 http://dx.doi.org/10.3389/fbioe.2021.639337 Text en Copyright © 2021 Mc Ardle, Pratt, Buckley, Del Din, Galna, Thomas, Rochester and Alcock. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Mc Ardle, Ríona
Pratt, Stephanie
Buckley, Christopher
Del Din, Silvia
Galna, Brook
Thomas, Alan
Rochester, Lynn
Alcock, Lisa
Balance Impairments as Differential Markers of Dementia Disease Subtype
title Balance Impairments as Differential Markers of Dementia Disease Subtype
title_full Balance Impairments as Differential Markers of Dementia Disease Subtype
title_fullStr Balance Impairments as Differential Markers of Dementia Disease Subtype
title_full_unstemmed Balance Impairments as Differential Markers of Dementia Disease Subtype
title_short Balance Impairments as Differential Markers of Dementia Disease Subtype
title_sort balance impairments as differential markers of dementia disease subtype
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991998/
https://www.ncbi.nlm.nih.gov/pubmed/33777910
http://dx.doi.org/10.3389/fbioe.2021.639337
work_keys_str_mv AT mcardleriona balanceimpairmentsasdifferentialmarkersofdementiadiseasesubtype
AT prattstephanie balanceimpairmentsasdifferentialmarkersofdementiadiseasesubtype
AT buckleychristopher balanceimpairmentsasdifferentialmarkersofdementiadiseasesubtype
AT deldinsilvia balanceimpairmentsasdifferentialmarkersofdementiadiseasesubtype
AT galnabrook balanceimpairmentsasdifferentialmarkersofdementiadiseasesubtype
AT thomasalan balanceimpairmentsasdifferentialmarkersofdementiadiseasesubtype
AT rochesterlynn balanceimpairmentsasdifferentialmarkersofdementiadiseasesubtype
AT alcocklisa balanceimpairmentsasdifferentialmarkersofdementiadiseasesubtype